Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Investigation of the mutual pharmacokinetic interactions between bosentan, a dual endothelin receptor antagonist, and simvastatin.
Dingemanse J, Schaarschmidt D, van Giersbergen PL. Dingemanse J, et al. Among authors: van giersbergen pl. Clin Pharmacokinet. 2003;42(3):293-301. doi: 10.2165/00003088-200342030-00004. Clin Pharmacokinet. 2003. PMID: 12603176 Clinical Trial.
Influence of food intake and formulation on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist.
Dingemanse J, Bodin F, Weidekamm E, Kutz K, van Giersbergen P. Dingemanse J, et al. J Clin Pharmacol. 2002 Mar;42(3):283-9. doi: 10.1177/00912700222011300. J Clin Pharmacol. 2002. PMID: 11865964 Clinical Trial.
Multiple-dose pharmacokinetics of intranasally administered IS-159 in healthy subjects.
Van Giersbergen PL, Dingemanse J. Van Giersbergen PL, et al. Eur J Drug Metab Pharmacokinet. 2003 Jan-Mar;28(1):49-54. doi: 10.1007/BF03190866. Eur J Drug Metab Pharmacokinet. 2003. PMID: 14503664 Clinical Trial.
Clinical pharmacology of bosentan, a dual endothelin receptor antagonist.
Dingemanse J, van Giersbergen PL. Dingemanse J, et al. Among authors: van giersbergen pl. Clin Pharmacokinet. 2004;43(15):1089-115. doi: 10.2165/00003088-200443150-00003. Clin Pharmacokinet. 2004. PMID: 15568889 Review.
Mutual pharmacokinetic interactions between bosentan and lopinavir/ritonavir in healthy participants.
Dingemanse J, van Giersbergen PL, Patat A, Nilsson PN. Dingemanse J, et al. Among authors: van giersbergen pl. Antivir Ther. 2010;15(2):157-63. doi: 10.3851/IMP1506. Antivir Ther. 2010. PMID: 20386070 Clinical Trial.
Treatment of secondary pulmonary hypertension with bosentan and its pharmacokinetic monitoring in ESRD.
Liefeldt L, van Giersbergen PL, Dingemanse J, Rudolph B, Walde T, Budde K, Neumayer HH, Hocher B. Liefeldt L, et al. Among authors: van giersbergen pl. Am J Kidney Dis. 2004 May;43(5):923-6. doi: 10.1053/j.ajkd.2003.12.054. Am J Kidney Dis. 2004. PMID: 15112184
Comparative investigation of the pharmacokinetics of bosentan in Caucasian and Japanese healthy subjects.
van Giersbergen PL, Dingemanse J. van Giersbergen PL, et al. J Clin Pharmacol. 2005 Jan;45(1):42-7. doi: 10.1177/0091270004270833. J Clin Pharmacol. 2005. PMID: 15601804 Clinical Trial.
Pharmacokinetics and pharmacodynamics of the urotensin-II receptor antagonist palosuran in healthy male subjects.
Sidharta PN, van Giersbergen PL, Dingemanse J. Sidharta PN, et al. Among authors: van giersbergen pl. J Clin Pharmacol. 2009 Oct;49(10):1168-75. doi: 10.1177/0091270009341181. Epub 2009 Jul 22. J Clin Pharmacol. 2009. PMID: 19625629 Clinical Trial.
Multiple-Dose Pharmacokinetics, Pharmacodynamics, and Safety of the Urotensin-II Receptor Antagonist Palosuran in Healthy Male Subjects.
Sidharta PN, van Giersbergen PLM, Dingemanse J. Sidharta PN, et al. Among authors: van giersbergen plm. Pharmacology. 2018;102(5-6):339-346. doi: 10.1159/000492936. Epub 2018 Nov 1. Pharmacology. 2018. PMID: 30384375 Clinical Trial.
Investigation of mutual pharmacokinetic interactions between macitentan, a novel endothelin receptor antagonist, and sildenafil in healthy subjects.
Sidharta PN, van Giersbergen PL, Wolzt M, Dingemanse J. Sidharta PN, et al. Among authors: van giersbergen pl. Br J Clin Pharmacol. 2014 Nov;78(5):1035-42. doi: 10.1111/bcp.12447. Br J Clin Pharmacol. 2014. PMID: 24962473 Free PMC article. Clinical Trial.
74 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback